Author

Mengying Xie

Institution: Hebei Food Inspection and Research Institute

Observed institutions: Hubei University of Medicine, China Pharmaceutical University, Wuhan University, Taihe Hospital, Hebei Food Inspection and Research Institute, State Key Laboratory of Natural Medicine

ORCID: 0000-0002-3499-2146

Observed ORCID: 0000-0002-3499-2146

OpenAlex ID: A5101963802

A vitamin-responsive mesoporous nanocarrier with DNA aptamer-mediated cell targeting

2013 · Le-Le Li, Mengying Xie, et al. · Chemical Communications · 55

Gas-mediated cancer therapy

2020 · Hang Zhang, Mengying Xie, et al. · Environmental Chemistry Letters · 43

A TRAIL-Delivered Lipoprotein-Bioinspired Nanovector Engineering Stem Cell-Based Platform for Inhibition of Lung Metastasis of Melanoma

2019 · Kerong Chen, Xiaoqing Cao, et al. · Theranostics · 43

Leveraging nano-engineered mesenchymal stem cells for intramedullary spinal cord tumor treatment

2022 · Lu Tang, Mengying Xie, et al. · Chinese Chemical Letters · 31

Intracranial delivery of synthetic mRNA to suppress glioblastoma

2021 · Hao Peng, Xingrong Guo, et al. · Molecular Therapy — Oncolytics · 30

Macrophage Membrane Camouflaged Lipoprotein Nanoparticle for Effective Obesity Treatment Based on a Sustainable Self-Reinforcement Strategy

2022 · Yujie Su, Wei Wang, et al. · Acta Biomaterialia · 27

Mesenchymal Stem Cells Mediated Drug Delivery in Tumor-Targeted Therapy

2020 · Mengying Xie, Lei Tao, et al. · Current Drug Delivery · 24

Research on quantitative detection technology of raccoon‐derived ingredient adulteration in sausage products

2024 · Hui Wang, Chen Chen, et al. · Food Science & Nutrition

Works count: 8

Citation count: 253

H-index: 7

I10-index: 7